BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
IGC Pharma
IGC
$29.2M
| $286K | ﹤0.01% |
715,440
-2,444
| -0.3% | -$759 |
|
4302
Gain Therapeutics
GANX
$85.7M
| $284K | ﹤0.01% |
75,398
+47,787
| +173% | +$198K |
|
4303
AMREP Corp
AXR
$114M
| $282K | ﹤0.01% |
12,121
-189
| -2% | -$4.11K |
|
4304
Orion Energy Systems
OESX
$80.7M
| $281K | ﹤0.01% |
32,324
-191
| -0.6% | -$1.88K |
|
4305
SELLAS Life Sciences
SLS
$2.17B
| $281K | ﹤0.01% |
278,218
-1,586
| -0.6% | -$1.33K |
|
|
FORA
4306
DELISTED
Forian
FORA
| $281K | ﹤0.01% |
84,534
-980
| -1% | -$2.84K |
|
4307
KULR Technology Group
KULR
$129M
| $276K | ﹤0.01% |
90,893
| – | – |
|
|
BCLI
4308
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $276K | ﹤0.01% |
32,621
+1,531
| +5% | +$8.42K |
|
4309
First Seacoast Bancorp
FSEA
$80.5M
| $274K | ﹤0.01% |
32,739
-257
| -0.8% | -$2.17K |
|
4310
CPS Technologies
CPSH
$86.1M
| $274K | ﹤0.01% |
148,252
-3,017
| -2% | -$6.73K |
|
4311
Kewaunee Scientific
KEQU
$106M
| $274K | ﹤0.01% |
7,970
-475
| -6% | -$14.1K |
|
4312
Owlet
OWLT
$163M
| $271K | ﹤0.01% |
62,899
| – | – |
|
4313
NewAmsterdam Pharma
NAMS
$3.3B
| $265K | ﹤0.01% |
11,220
-11,721
| -51% | -$238K |
|
|
PPSI
4314
Pioneer Power Solutions
PPSI
$32.3M
| $265K | ﹤0.01% |
46,355
-213
| -0.5% | -$1.12K |
|
4315
Landmark Bancorp
LARK
$196M
| $265K | ﹤0.01% |
15,127
-1,191
| -7% | -$21.5K |
|
|
NFGC
4316
New Found Gold
NFGC
$634M
| $263K | ﹤0.01% |
71,068
+39,567
| +126% | +$132K |
|
4317
GSI Technology
GSIT
$247M
| $261K | ﹤0.01% |
76,798
-1,237
| -2% | -$3.57K |
|
4318
Oramed Pharmaceuticals
ORMP
$176M
| $261K | ﹤0.01% |
89,295
+1,537
| +2% | +$4.3K |
|
4319
ClearSign Technologies
CLIR
$27.8M
| $258K | ﹤0.01% |
26,759
-910
| -3% | -$9.69K |
|
4320
iShares iBonds Oct 2027 Term TIPS ETF
IBID
$121M
| $256K | ﹤0.01% |
10,000
-10,000
| -50% | -$254K |
|
|
PRT
4321
PermRock Royalty Trust Unit
PRT
$27M
| $254K | ﹤0.01% |
60,713
+55,402
| +1,043% | +$246K |
|
4322
Bel Fuse Inc Class A
BELFA
$3.35B
| $253K | ﹤0.01% |
3,570
+151
| +4% | +$10.1K |
|
4323
Traws Pharma
TRAW
$8.22M
| $251K | ﹤0.01% |
9,955
| – | – |
|
4324
Schwab US Large- Cap ETF
SCHX
$74.2B
| $248K | ﹤0.01% |
12,006
+6
| +0.1% | +$118 |
|
|
LVROW
4325
DELISTED
Lavoro Ltd Warrant
LVROW
| $248K | ﹤0.01% |
495,466
| – | – |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.